Literature DB >> 2472536

Treatment of drug-induced agranulocytosis with granulocyte-colony stimulating factor.

K Muroi, M Ito, R Sasaki, T Suda, S Sakamoto, Y Miura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2472536     DOI: 10.1016/s0140-6736(89)90305-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

Review 2.  Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions.

Authors:  L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

3.  Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor (rh G-CSF).

Authors:  A Willfort; C Lorber; S Kapiotis; S Sertl; R Hainz; P Kirchweger; U Jäger; P A Kyrle; K Lechner; K Geissler
Journal:  Ann Hematol       Date:  1993-05       Impact factor: 3.673

Review 4.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

5.  Risks of rhG-CSF treatment in drug-induced agranulocytosis.

Authors:  H Demuynck; P Zachée; G E Verhoef; M Schetz; G Van den Berghe; P Lauwers; M A Boogaerts
Journal:  Ann Hematol       Date:  1995-03       Impact factor: 3.673

6.  Agranulocytosis induced by antithyroid therapy: effects of treatment with granulocyte colony stimulating factor.

Authors:  D Adorf; K H Grajer; W Kaboth; C Nerl
Journal:  Clin Investig       Date:  1994-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.